Page last updated: 2024-11-06

traxanox

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

traxanox: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID68784
CHEMBL ID2009696
CHEBI ID135269
SCHEMBL ID29628
MeSH IDM0073672

Synonyms (20)

Synonym
NCI60_002899
traxanox sodium
traxanox [inn]
9-chloro-7-(1h-tetrazol-5-yl)-5h-(1)benzopyrano(2,3-b)pyridin-5-one
5h-(1)benzopyrano(2,3-b)pyridin-5-one, 9-chloro-7-(1h-tetrazol-5-yl)-
9-chloro-5-oxo-7-(1h-tetrazol-5-yl)-5h-(1)benzopyrano(2,3-b)pyridine
traxanoxum [inn-latin]
9-chloro-7-(1h-tetrazol-5-yl)-5h-(1)benzopyrano(2,3-b)pyridine-5-one
traxanox
CHEBI:135269
9-chloro-7-(2h-tetrazol-5-yl)chromeno[2,3-b]pyridin-5-one
hdu53a8a4s ,
unii-hdu53a8a4s
58712-69-9
traxanoxum
CHEMBL2009696
SCHEMBL29628
traxanox [mi]
DTXSID50207421
Q27279881

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
pyridochromeneAn organic heterotricyclic compound composed of a pyridine ring fused to a chromene.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-199022 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.23 (24.57)
Research Supply Index3.22 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (9.09%)5.53%
Reviews1 (4.55%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (86.36%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]